Search
for
Sort by
Research 391–420 of 1000+
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Treatment options for alopecia areata
- Unusual acute lupus hemophagocytic syndrome – a test of diagnostic criteria: a case report
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata after COVID-19 Vaccines
- Differentiation of frontal fibrosing alopecia and Lichen planopilaris on trichoscopy: A comprehensive review
- Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- Mesenchymal Stem Cells for the Treatment of Skin Diseases
- Alopecia areata: current concepts
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Stem cell-based therapies for alopecia areata: a narrative review
- The Utility of Ultraviolet Dermoscopy in Identifying White Hairs in Children: A Diagnostic Aid
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Potential Cosmetic Applications of Dihydroartemisinin
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Abstracts from the 2024 WDS Forum - virtual option
- Stem-cell therapy in dermatology – Challenges and opportunities
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Entdeckung von Autoantigenen bei der Haarverluststörung Alopecia areata: Implikation von posttranslationalen Modifikationen
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Peculiarities of clinical course and diagnostic of alopecia areata with comorbidity. Clinical observations
- Areata-Like Lupus as a Clinical Manifestation of Cutaneous Lupus Erythematosus
- SnapshotDx Quiz: May 2020